前庭眼动康复仪治疗前庭性眩晕患者的临床疗效观察OACSTPCD

Objective To investigate the clinical effectiveness of a vestibular-ocular motor rehabilitation device for vestibular vertigo.Methods A total of 102 patients with vestibular vertigo visiting our hospital from September 2021 to February 2023 were assigned to receive either treatment with betahistine mesylate tablets and vestibular-ocular motor reha-bilitation(group A,n=51)or treatment with betahistine mesylate tablets alone(group B,n=51).The Dizziness Handi-cap Inventory(DHI)score,Berg balance scale score,time consumed in the rising-walking test,clinical response,ocular motor abnormalities,and vestibular abnormalities were compared between the two groups using the t test and chi-square test.Results The overall response rate was significantly higher in group A than in group B(95.83%vs.81.23%,P<0.05).After treatment,both groups showed significant reductions in the DHI score,time consumed in the rising-walking test,the rate of ocular motor abnormalities,and the rate of vestibular abnormalities;and these indicators were signifi-cantly lower in group A than group B(all P<0.05).The Berg balance scale score was significantly increased after treat-ment in both groups,with a significantly higher score in group A than in group B(both P<0.05).Conclusion The vestibular-ocular motor rehabilitation device can relieve vertigo symptoms,improve vestibular function,and strengthen balance and walking abilities in patients with vestibular vertigo.